Ovarian Endometrioid Tumor Recruiting Phase 1 / 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0073747 (Ovarian Endometrioid Tumor)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02627443Carboplatin, Gemcitabine Hydrochloride, and ATR Kinase Inhibitor VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube CancerTreatment